Abstract
Somatostatin (somatotropin release inhibiting factor) is an abundant neuropeptide, which acts on five subtypes of somatostatin receptor (SST1-SST5; nomenclature as agreed by the NC-IUPHAR Subcommittee on Somatostatin Receptors [89]). Activation of these receptors produces a wide range of physiological effects throughout the body including the inhibition of secretion of many hormones. Endogenous ligands for these receptors are somatostatin-14 (SRIF-14) and somatostatin-28 (SRIF-28). cortistatin-14 has also been suggested to be an endogenous ligand for somatostatin receptors [56].
Cite
CITATION STYLE
Bosquet, C., Castaño, J. P., Csaba, Z., Culler, M., Dournaud, P., Epelbaum, J., … Wester, H.-J. (2019). Somatostatin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database. IUPHAR/BPS Guide to Pharmacology CITE, 2019(4). https://doi.org/10.2218/gtopdb/f61/2019.4
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.